- Organizations: Provectus Biopharmaceuticals
Business
VisiRose raises $3M to advance RB-PDAT therapeutic toward regulatory approval
Funding will support ongoing clinical development of photodynamic therapy candidate for infectious keratitis and future IND submission to FDA.Research